Infrequent development of drug resistance in HIV-1-infected treatment-naive subjects after 96 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate
Margot, Nicolas, Cox, Stephanie, Das, Moupali, McCallister, Scott, Miller, Michael D, Callebaut, ChristianYear:
2017
Language:
english
Journal:
Antiviral Therapy
DOI:
10.3851/IMP3125
File:
PDF, 83 KB
english, 2017